Evidence map›Paper›PMID 12475393›Full record

ArticleThe Biochemical journal2003

Cbl-ArgBP2 complex mediates ubiquitination and degradation of c-Abl.

Philippe Soubeyran, Ana Barac, Iwona Szymkiewicz, Ivan Dikic

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Ubiquitin-Proteasome System in Apoptosis and Apoptotic Cell Clearance.Frontiers in cell and developmental biology · 2022
    Review
  5. eLife · 2021
    Article
  6. Article
  7. Article
  8. Ponatinib and other CML Tyrosine Kinase Inhibitors in Thrombosis.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. nArgBP2 regulates excitatory synapse formation by controlling dendritic spine morphology.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Philippe SoubeyranLudwig Institute for Cancer Research, Box 595, Husargatan 3, Uppsala, S-75124, Sweden.
Ana Barac
Iwona Szymkiewicz
Ivan Dikic
Ludwig Cancer Research · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanisms leading to the ubiquitination and degradation of the activated c-Abl kinase have not yet been identified. We found that the multi-adaptor protein ArgBP2 links c-Abl to the ubiquitin ligase Cbl. Phosphorylation of Cbl and ArgBP2 by c-Abl resulted in the stabilization of their interactions, thus facilitating Cbl-induced ubiquitination and subsequent degradation of c-Abl and ArgBP2.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCHO CellsCricetinaeHomeodomain ProteinsHumansHydrolysisOncogene Protein v-cblPhosphorylationProtein BindingProto-Oncogene Proteins c-ablRetroviridae Proteins, OncogenicRNA-Binding ProteinsTwo-Hybrid System TechniquesUbiquitinAdaptor Proteins, Signal TransducingHomeodomain ProteinsOncogene Protein v-cblProto-Oncogene Proteins c-ablRetroviridae Proteins, OncogenicRNA-Binding ProteinsSORBS2 protein, humanUbiquitin

Identifiers

PMID12475393
PMCPMC1223168
OpenAlexW2145462118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.